Ever since Moderna and Pfizer-BioNTech have started the variant-specific vaccine’s clinical trials, the international community of researchers and scientists are arguing about the necessity, need or sustainability of such variant-specific vaccines

India has to scale up testing, isolating and sequencing along with vaccination and decentralized critical care to face large-scale future outbreaks, say experts